494 330

Cited 67 times in

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set.

Authors
 Eun Sung Park  ;  Rosalia Rabinovsky  ;  Mark Carey  ;  Bryan T. Hennessy  ;  Roshan Agarwal  ;  Wenbin Liu  ;  Zhenlin Ju  ;  Wanleng Deng  ;  Yiling Lu  ;  Hyun Goo Woo  ;  Sang-Bae Kim  ;  Jae-Ho Cheong  ;  Levi A. Garraway  ;  John N. Weinstein  ;  Gordon B. Mills  ;  Ju-Seog Lee  ;  Michael A. Davies 
Citation
 MOLECULAR CANCER THERAPEUTICS, Vol.9(2) : 257-267, 2010 
Journal Title
 MOLECULAR CANCER THERAPEUTICS 
ISSN
 1535-7163 
Issue Date
2010
MeSH
Antineoplastic Agents/therapeutic use* ; Cell Line, Tumor* ; Cluster Analysis ; Drug Screening Assays, Antitumor/instrumentation* ; Drug Screening Assays, Antitumor/methods* ; Humans ; Mutation* ; National Cancer Institute (U.S.) ; Proteomics/methods* ; Signal Transduction ; United States
Abstract
Aberrations in oncogenes and tumor suppressors frequently affect the activity of critical signal transduction pathways. To analyze systematically the relationship between the activation status of protein networks and other characteristics of cancer cells, we did reverse phase protein array (RPPA) profiling of the NCI60 cell lines for total protein expression and activation-specific markers of critical signaling pathways. To extend the scope of the study, we merged those data with previously published RPPA results for the NCI60. Integrative analysis of the expanded RPPA data set revealed five major clusters of cell lines and five principal proteomic signatures. Comparison of mutations in the NCI60 cell lines with patterns of protein expression showed significant associations for PTEN, PIK3CA, BRAF, and APC mutations with proteomic clusters. PIK3CA and PTEN mutation enrichment were not cell lineage-specific but were associated with dominant yet distinct groups of proteins. The five RPPA-defined clusters were strongly associated with sensitivity to standard anticancer agents. RPPA analysis identified 27 protein features significantly associated with sensitivity to paclitaxel. The functional status of those proteins was interrogated in a paclitaxel whole genome small interfering RNA (siRNA) library synthetic lethality screen and confirmed the predicted associations with drug sensitivity. These studies expand our understanding of the activation status of protein networks in the NCI60 cancer cell lines, demonstrate the importance of the direct study of protein expression and activation, and provide a basis for further studies integrating the information with other molecular and pharmacological characteristics of cancer.
Files in This Item:
T201005441.pdf Download
DOI
10.1158/1535-7163.MCT-09-0743
Appears in Collections:
5. Research Institutes (연구소) > Institute for Medical Convergence (연의-생공연 메디컬융합연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Park, Eun Sung(박은성)
Cheong, Jae Ho(정재호) ORCID logo https://orcid.org/0000-0002-1703-1781
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/103090
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links